Combinatorics

Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

Retrieved on: 
Friday, March 22, 2024
MYGN, Diagnosis, Genetic testing, Patent, Combinatorics, Genetics, Patient, Neoplasm, Research, DNA, Myriad Genetics, Doctor of Philosophy, Oncology, Medicine, University, MD Anderson Cancer Center, MRD, Intellectual property, FDA, Estate (law), Pharmaceutical industry

U.S. patent 11,932,910, entitled Combinatorial DNA Screening, covers Myriad’s foundational and proprietary method of preparing cell free DNA.

Key Points: 
  • U.S. patent 11,932,910, entitled Combinatorial DNA Screening, covers Myriad’s foundational and proprietary method of preparing cell free DNA.
  • This method describes a key aspect of tumor-informed MRD assays that detect circulating tumor DNA (ctDNA) through sequencing.
  • Specifically, the patented method relates to the manner in which a sample is sufficiently enriched with ctDNA that it can be detected, if present, with high sensitivity and specificity.
  • “The 2016 filing date of this patent—at the advent of MRD development—highlights Myriad’s foresight about the potential role of tumor-derived cell-free DNA in the expanding field of cancer diagnostics,” said Paul J. Diaz, President and CEO, Myriad Genetics.

Nature Communications Publishes Zapata AI Research on Generative AI for Optimization

Retrieved on: 
Tuesday, April 2, 2024
Data Management, Apps, Applications, Technology, Software, Networks, Artificial Intelligence, Physics, Synthetic media, Algorithm, Combinatorics, MIT, Risk, Research, Emiliano Zapata, Blog, ArXiv, BMW, GEO, Language, Generative, Nature Communications, Medical device

Zapata Computing Holdings Inc. (“Zapata AI”) (Nasdaq: ZPTA), the Industrial Generative AI company, today announced that its foundational research on generator-enhanced optimization (GEO) has been published in the esteemed Nature Communications journal.

Key Points: 
  • Zapata Computing Holdings Inc. (“Zapata AI”) (Nasdaq: ZPTA), the Industrial Generative AI company, today announced that its foundational research on generator-enhanced optimization (GEO) has been published in the esteemed Nature Communications journal.
  • The research, titled “Enhancing Combinatorial Optimization with Classical and Quantum Generative Models,” introduces Generator-Enhanced Optimization (GEO), a novel optimization method that leverages the power of generative modeling to suggest high-quality candidate solutions to complex optimization problems.
  • It is the second Zapata AI paper on generative AI to be published in Nature Communications since December 2023 .
  • The GEO paper reflects the results of a pioneering effort to apply generative AI to portfolio optimization and other optimization problems.

$10 million Artificial Intelligence Mathematical Olympiad Prize appoints advisory committee members

Retrieved on: 
Wednesday, February 7, 2024
Tao, XTX, University College London, University, Machine learning, UCLA, Sequoia, Female, Engineer, Marshall Scholarship, United Kingdom Mathematics Trust, W. W. Rouse Ball, Breakthrough Prize, Principle, Silver, Sequoia Capital, Advisory Committee, Fields Medal, Gold, Salesforce, Game theory, Carnegie Mellon University, Artificial intelligence, Salem Prize, Trinity College, Royal Society, Research, Scientist, Princeton University, Crafoord, Doctor of Philosophy, Combinatorics, MacArthur Fellows Program, XTX Markets, Cambridge University Press, AI, PDE, Education, Diffeomorphism, MIT, Timothy Gowers, Prize, Management

LONDON, Feb. 7, 2024 /PRNewswire/ -- XTX Markets' newly created Artificial Intelligence Mathematical Olympiad Prize ('AIMO Prize') is a $10mn challenge fund designed to spur the creation of a publicly shared AI model capable of winning a gold medal in the International Mathematical Olympiad (IMO).

Key Points: 
  • Fields Medallists Timothy Gowers and Terence Tao appointed to the Advisory Committee for the Artificial Intelligence Mathematical Olympiad Prize, alongside Po-Shen Loh, Dan Roberts and Geoff Smith.
  • The AIMO Advisory Committee will support the development of the AIMO Prize, including advising on appropriate protocols and technical aspects, and designing the various competitions and prizes.
  • It will be important to experiment with multiple approaches to this goal, and to benchmark the performance of each of them.
  • Eoghan Flanagan, Director of the AIMO Prize, commented:
    "We are delighted to welcome such esteemed members of the mathematical community to the advisory committee of the AIMO Prize.

$10 million Artificial Intelligence Mathematical Olympiad Prize appoints advisory committee members

Retrieved on: 
Wednesday, February 7, 2024
Tao, XTX, University College London, University, Machine learning, UCLA, Sequoia, Female, Engineer, Marshall Scholarship, United Kingdom Mathematics Trust, W. W. Rouse Ball, Breakthrough Prize, Principle, Silver, Sequoia Capital, Advisory Committee, Fields Medal, Gold, Salesforce, Game theory, Artificial intelligence, Salem Prize, Trinity College, Royal Society, Research, Scientist, Princeton University, Crafoord, Doctor of Philosophy, Combinatorics, MacArthur Fellows Program, XTX Markets, Cambridge University Press, AI, PDE, Education, Diffeomorphism, MIT, Timothy Gowers, Prize, Management

LONDON, Feb. 7, 2024 /PRNewswire/ -- XTX Markets' newly created Artificial Intelligence Mathematical Olympiad Prize ('AIMO Prize') is a $10mn challenge fund designed to spur the creation of a publicly shared AI model capable of winning a gold medal in the International Mathematical Olympiad (IMO).

Key Points: 
  • Fields Medallists Timothy Gowers and Terence Tao appointed to the Advisory Committee for the Artificial Intelligence Mathematical Olympiad Prize, alongside Po-Shen Loh, Dan Roberts and Geoff Smith.
  • The AIMO Advisory Committee will support the development of the AIMO Prize, including advising on appropriate protocols and technical aspects, and designing the various competitions and prizes.
  • It will be important to experiment with multiple approaches to this goal, and to benchmark the performance of each of them.
  • Eoghan Flanagan, Director of the AIMO Prize, commented:
    "We are delighted to welcome such esteemed members of the mathematical community to the advisory committee of the AIMO Prize.

The Future of Conversational AI Requires Combinatorial AI

Retrieved on: 
Thursday, August 17, 2023
Knowledge, Research report, Counties of South Sudan, Gartner, Sole, Research, Conversation, Information Today, Gartner hype cycle, Combinatorics, Chatbot, Ideation, AI, EWeek, Customer service, Management

BRIDGEWATER, N.J., Aug. 17, 2023 /PRNewswire/ -- Openstream.ai, the leading provider of plan-based, multimodal Conversational AI solutions for visionaries, today announced its platform, Eva™, was named in the Gartner® Emerging Tech: Use Generative AI to Transform Conversational AI Solutions research report. This is the fifth time in 2023 that its Conversational AI platform, Eva™ has been recognized within Gartner Emerging Tech research reports and compliments an earlier announcement of its recognition within multiple 2023 Gartner Hype Cycle® reports.

Key Points: 
  • BRIDGEWATER, N.J., Aug. 17, 2023 /PRNewswire/ -- Openstream.ai , the leading provider of plan-based, multimodal Conversational AI solutions for visionaries, today announced its platform, Eva™, was named in the Gartner® Emerging Tech: Use Generative AI to Transform Conversational AI Solutions research report.
  • Gartner's report defines Combinatorial AI as "using multiple emerging AI technologies and trends in combination to uncover new and better values and capabilities."
  • The research observes that with an increased focus on explaining AI models and integrating responsible AI techniques, Combinatorial AI is opening up new opportunities and forcing many providers to reframe the business value of use cases such as VAs for sales or recruitment, AI avatars in a digital workplace, and conversational front ends for intelligent applications.
  • Eva's sophistication as a Multimodal Conversational AI platform empowers our clients to continue to take full advantage of Combinatorial AI."

Pillar Biosciences and KeyGene Enter into Licensing Agreement

Retrieved on: 
Thursday, April 13, 2023
Pillar, NGS, Research, Combinatorics, RUO, Patent, Laboratory, IVD, Keygen, Health, Pension fund, Column

NATICK, Mass.

Key Points: 
  • NATICK, Mass.
  • and WAGENINGEN, Netherlands, April 13, 2023 /PRNewswire/ -- Pillar Biosciences , Inc., the leader in Decision Medicine™, which develops and distributes next-generation sequencing (NGS) tests to localize testing and reduce time to treatment initiation and testing costs, today announced a non-exclusive licensing agreement with Keygene N.V. related to their patent family entitled Combinatorial sequence barcodes for high throughput screening for use in Pillar Biosciences products, kits or services used for research or clinical testing.
  • "Pillar Biosciences is committed to developing, manufacturing and delivering high-value IVD & RUO kitted solutions and supporting technologies that can be performed locally by laboratories running NGS sequencing," said Randy Pritchard, CEO of Pillar Biosciences, Inc. "This license, in combination with our existing broad patent portfolio, helps Pillar confidently enable laboratories around the globe with diagnostic assays that can be performed in a low-cost, high-multiplexed manner, enabling actionable, accessible NGS results."
  • "It is great to see another example of societal relevance of KeyGene's technology innovation in the field of human health," said Prof. Dr. Roeland van Ham, CEO of Keygene N.V. "We trust that the use of some of our innovations in next-generation sequencing will support Pillar Bioscience in realizing their ambition to contribute to better-informed patient treatment".

DiNAQOR Appoints Two Seasoned Executives to Leadership Team

Retrieved on: 
Monday, January 9, 2023
Nephrology, Paul D. Wellstone Muscular Dystrophy Community Assistance, Research and Education Amendments of 2013, Biotechnology, Duke University Hospital, Combinatorics, Therapy, PKD, Boston Scientific, NDA, Research, Growth, Patient, PKD Foundation, AstraZeneca, Neurology, Sanofi, Hematology, Immunology, Diabetes, Rusconi (band), Management, Pharmaceutical industry

SCHLIEREN, Switzerland, Jan. 9, 2023 /PRNewswire/ -- DiNAQOR, a genetic medicine platform company, today announced that it has added to its leadership team with the appointments of two veteran biotechnology executives. Chris Rusconi, Ph.D., who brings decades of experience in global pharmaceutical development, will serve as DiNAQOR's Chief Development Officer. Steven Zelenkofske, D.O., M.S., an expert in clinical development and adaptive trial design and operations who serves on DiNAQOR's board of directors, will assume the role of Chief Strategy Officer.

Key Points: 
  • Chris Rusconi to serve as Chief Development Officer; Steven Zelenkofske to take role of Chief Strategy Officer as DiNAQOR continues rapid growth
    SCHLIEREN, Switzerland, Jan. 9, 2023 /PRNewswire/ -- DiNAQOR , a genetic medicine platform company, today announced that it has added to its leadership team with the appointments of two veteran biotechnology executives.
  • Chris Rusconi, Ph.D. , who brings decades of experience in global pharmaceutical development, will serve as DiNAQOR's Chief Development Officer.
  • "We are fortunate to add Chris and Steve's expertise to DiNAQOR's leadership at such a pivotal time for our company," said Johannes Holzmeister, M.D., Chairman and CEO of DiNAQOR.
  • "Taking on a leadership role with DiNAQOR is an exciting opportunity and the beginning of a new chapter for me," Dr. Rusconi said.

NTT Scientists Co-author 11 Papers Selected for NeurIPS 2021

Retrieved on: 
Monday, December 6, 2021
Science, Software, Other Science, Research, Data Management, Technology, Other Technology, Security, Benchmark, 2021 Essex County Council election, Relaxation, NLD, CIS, PVI, Classification, CGMS-A, Machine learning, Silicon, General officer, Neuroscience, Role, Medicine, View, Research, DRE, Learning, Information, Phi Lab, MEI, KSB, Physics, Document classification, DNN, Social informatics, Combinatorics, Photonics, Labs, Solution, CCG, NTT, Comenius University Faculty of Mathematics, Physics and Informatics, SGD, Nippon Telegraph and Telephone, MAP, Efficiency, DRS, Poster, PHI, Element, CGM, Behavior, Deep learning, Path integral formulation, F1, Application, Laboratory, Conference on Neural Information Processing Systems, Cryptography, Communication studies, RAFT, Data science, Name, Graphical model, Mobile phone, Risk management, Typesetting

(TYO:9432), today announced that 11 papers co-authored by researchers from several of their laboratories were selected for presentation at NeurIPS 2021 , the 35th annual conference of the Neural Information Processing Systems Foundation.

Key Points: 
  • (TYO:9432), today announced that 11 papers co-authored by researchers from several of their laboratories were selected for presentation at NeurIPS 2021 , the 35th annual conference of the Neural Information Processing Systems Foundation.
  • Taking place from Dec. 6 to Dec. 14, scientists from the NTT Research Physics & Informatics (PHI) Lab and Cryptography & Information Security (CIS) Lab are presenting four papers.
  • Scientists from NTT Corps Computer and Data Science (CD), Human Informatics (HI), Social Informatics (SI) and Communication Science (CS) Labs are presenting seven papers.
  • NTT and the NTT logo are registered trademarks or trademarks of NIPPON TELEGRAPH AND TELEPHONE CORPORATION and/or its affiliates.

Aegis Launches COVID-19 Testing Program for Schools

Retrieved on: 
Thursday, June 10, 2021
Professional services, Pharmaceutical, Preschool, Other Education, Infectious diseases, University, Primary, Secondary, Education, Science, Consulting, Other Science, Health, Articles, Contemporary history, Health, Combinatorics, Design of experiments, Group testing, COVID-19 pandemic

to help keep schools open during the COVID-19 pandemic through pooled testing.

Key Points: 
  • to help keep schools open during the COVID-19 pandemic through pooled testing.
  • This testing program was designed to be simple for schools to use while reducing costs and increasing access to testing.
  • to make ongoing testing easy for teachers and students, so schools can safely and confidently remain open.
  • Aegis tests and reports each pool, and follow-up testing is recommended for each student or staff in a positive pool.

Cutting-edge Scale-Out Technology from Toshiba will Take Fintech and Logistics to New Level

Retrieved on: 
Thursday, March 11, 2021
Networks, Hardware, Electronic design automation, Engineering, Technology, Semiconductor, Manufacturing, Other Technology, Companies, Industry economics), Economy of Japan, Mitsui, Toshiba, Combinatorial optimization, Mathematical optimization, Optimization problem, Financial technology, Combinatorics

Aiming to bring higher efficiencies to these and other businesses, Toshiba has addressed combinatorial optimization problems by developing high-speed, high-accuracy algorithms and corresponding practical computer solutions*2.

Key Points: 
  • Aiming to bring higher efficiencies to these and other businesses, Toshiba has addressed combinatorial optimization problems by developing high-speed, high-accuracy algorithms and corresponding practical computer solutions*2.
  • We hope the new technology will take fintech and logistic to a new level.
  • *1 K. Tatsumura et al., Scaling-out Ising machine using a multi-chip architecture for simulated bifurcation, Nature Electronics 4, (2021).
  • Guided by the Basic Commitment of the Toshiba Group, Committed to People, Committed to the Future, Toshiba contributes to societys positive development with services and solutions that lead to a better world.